The impacts of undetected nonadherence in phase II, III and post-marketing clinical trials: An overview

Elise Le Flohic*, Bernard Vrijens, Mickael Hiligsmann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The impacts of undetected nonadherence in phase II, III and post-marketing clinical trials: An overview'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science